Efficacy and Safety of Dual-Drug-Eluting Stents for de Novo Coronary Lesions in South Korea-The Effect Trial.

Jung-Joon ChaGi Chang KimSeung Ho HurJang Ho BaeJae Woong ChoiDong-Kyu JinSeong Il WooSeung Uk LeeJong Seon ParkYun-Hyeong ChoCheol Ung ChoiDo-Sun LimTae Hoon Ahn

Published in: Journal of clinical medicine (2020)

Dual-DESs had similar clinical outcomes regarding efficacy and safety as conventional DES. Among the dual-DES, the DXR™ stent as a new generation dual-DES had more favorable clinical outcomes than the Cilotax™ stent.

Keyphrases

coronary artery
coronary artery disease
heart failure
randomized controlled trial
study protocol
left ventricular
adverse drug